OTCMKTS:MCUJF - Medicure Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 07/23/2019 08:00 AM ET)
Today's Range
Now: $3.5771
50-Day Range
MA: $3.74
52-Week Range
Now: $3.5771
Volume8 shs
Average Volume686 shs
Market Capitalization$53.37 million
P/E RatioN/A
Dividend YieldN/A
Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$22.46 million
Cash Flow$0.2097 per share
Book Value$4.15 per share


Net Income$3.03 million


Market Cap$53.37 million
Next Earnings Date8/21/2019 (Estimated)
OptionableNot Optionable

Receive MCUJF News and Ratings via Email

Sign-up to receive the latest news and ratings for MCUJF and its competitors with MarketBeat's FREE daily newsletter.

Medicure (OTCMKTS:MCUJF) Frequently Asked Questions

What is Medicure's stock symbol?

Medicure trades on the OTCMKTS under the ticker symbol "MCUJF."

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) posted its earnings results on Monday, May, 27th. The company reported ($0.14) earnings per share (EPS) for the quarter. The business earned $3.67 million during the quarter. Medicure had a negative return on equity of 0.17% and a negative net margin of 0.50%. View Medicure's Earnings History.

When is Medicure's next earnings date?

Medicure is scheduled to release their next quarterly earnings announcement on Wednesday, August 21st 2019. View Earnings Estimates for Medicure.

Has Medicure been receiving favorable news coverage?

Media coverage about MCUJF stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medicure earned a news impact score of 0.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Medicure.

Who are some of Medicure's key competitors?

What other stocks do shareholders of Medicure own?

Who are Medicure's key executives?

Medicure's management team includes the folowing people:
  • Dr. Albert David Friesen, Founder, Chairman, CEO & Pres (Age 72)
  • Mr. James F. Kinley, CFO & Sec. (Age 41)

How do I buy shares of Medicure?

Shares of MCUJF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medicure's stock price today?

One share of MCUJF stock can currently be purchased for approximately $3.5771.

How big of a company is Medicure?

Medicure has a market capitalization of $53.37 million and generates $22.46 million in revenue each year. View Additional Information About Medicure.

What is Medicure's official website?

The official website for Medicure is http://www.medicure.com/.

How can I contact Medicure?

Medicure's mailing address is 2 - 1250 WAVERLEY STREET, WINNIPEG A2, R3T 6C6. The company can be reached via phone at 204-487-7412 or via email at [email protected]

MarketBeat Community Rating for Medicure (OTCMKTS MCUJF)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  128 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  240
MarketBeat's community ratings are surveys of what our community members think about Medicure and other stocks. Vote "Outperform" if you believe MCUJF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCUJF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel